Clinical characteristics and outcome of cancer diagnosed during pregnancy
1
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
ObjectiveThe aim of this study is to describe the clinical characteristics and outcome of cancer diagnosed during pregnancy. MethodsThis is a retrospective cohort study of women who were diagnosed with cancer during pregnancy at a tertiary academic hospital between 1995 and 2013. Maternal characteristics, gestational age at diagnosis, and type, stage, symptoms and signs of cancer for each patient were retrieved from the medical records. The cancer treatment, pregnancy management and the subsequent perinatal and maternal outcomes for each cancer were assessed. ResultsA total of 87 women were diagnosed with cancer during pregnancy (172.6 cases per 100,000 deliveries). The most common cancer was breast cancer (n=20), followed by gastrointestinal (n=17), hematologic (n=13), thyroid (n=11), central nervous system (n=7), cervical (n=7), ovarian (n=5), lung (n=3), and other cancers (n=4). Eighteen (20.7%) patients terminated their pregnancies. In the 69 (79.3%) patients who maintained their pregnancies, one patient miscarried and 34 patients delivered preterm. Of the preterm babies, 24 (70.6%) were admitted to the neonatal intensive care unit and 3 (8.8%) of those expired. The maternal mortality rate was 31.0%, with highest rate seen with lung cancers (66.7%), followed by gastrointestinal (50.0%), central nervous system (50.0%), hematologic (30.8%), breast (25.0%), ovarian (20.0%) cervical (14.3%), and thyroid cancers (0%). ConclusionThe clinical characteristics and outcome of cancer during pregnancy were highly variable depending on the type of cancer. However, timely diagnosis and appropriate management of cancer during pregnancy may improve both maternal and neonatal outcome.
Abstract
ObjectiveThe aim of this study is to describe the clinical characteristics and outcome of cancer diagnosed during pregnancy. MethodsThis is a retrospective cohort study of women who were diagnosed with cancer during pregnancy at a tertiary academic hospital between 1995 and 2013. Maternal characteristics, gestational age at diagnosis, and type, stage, symptoms and signs of cancer for each patient were retrieved from the medical records. The cancer treatment, pregnancy management and the subsequent perinatal and maternal outcomes for each cancer were assessed. ResultsA total of 87 women were diagnosed with cancer during pregnancy (172.6 cases per 100,000 deliveries). The most common cancer was breast cancer (n=20), followed by gastrointestinal (n=17), hematologic (n=13), thyroid (n=11), central nervous system (n=7), cervical (n=7), ovarian (n=5), lung (n=3), and other cancers (n=4). Eighteen (20.7%) patients terminated their pregnancies. In the 69 (79.3%) patients who maintained their pregnancies, one patient miscarried and 34 patients delivered preterm. Of the preterm babies, 24 (70.6%) were admitted to the neonatal intensive care unit and 3 (8.8%) of those expired. The maternal mortality rate was 31.0%, with highest rate seen with lung cancers (66.7%), followed by gastrointestinal (50.0%), central nervous system (50.0%), hematologic (30.8%), breast (25.0%), ovarian (20.0%) cervical (14.3%), and thyroid cancers (0%). ConclusionThe clinical characteristics and outcome of cancer during pregnancy were highly variable depending on the type of cancer. However, timely diagnosis and appropriate management of cancer during pregnancy may improve both maternal and neonatal outcome.
참고문헌 (34)
- Cause of death statistics: 1995-2013 web-based report, "Korean Statistical Information Service", Korean Statistical Information Service, ~ (2014)
- Weisz B, "Impact and treatment of cancer during pregnancy", Expert Rev Anticancer Ther, 4, pp.889~902 (2004)
- Cancer incidence rate: 2012 web-based report, "Korean Statistical Information Service", Korean Statistical Information Service, ~ (2015)
- Simulated average childbearing age: 1993-2013 web-based report, "Korean Statistical Information Service", Korean Statistical Information Service, ~ (2014)
- Van Calsteren K, "Cancer during pregnancy : an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes", J Clin Oncol, 28, pp.683~689 (2010)
- Pavlidis NA, "Coexistence of pregnancy and malignancy", Oncologist, 7, pp.279~287 (2002)
- Weisz B, "Cancer in pregnancy : maternal and fetal implications", Hum Reprod Update, 7, pp.384~393 (2001)
- Dunkelberg JC, "Gastrointestinal, pancreatic, and hepatic cancer during pregnancy", Obstet Gynecol Clin North Am, 32, pp.641~660 (2005)
- United States cancer statistics: 1999-2011 incidence and mortality web-based report, "US Cancer Statistics Working Group", Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, ~ (2014)
- Antonelli NM, "Cancer in pregnancy: a review of the literature. Part I", Obstet Gynecol Surv, 51, pp.125~134 (1996)
- Andersson TM, "Cancer during pregnancy and the postpartum period : a population-based study", Cancer, 121, pp.2072~2077 (2015)
- Eibye S, "Incidence of pregnancyassociated cancer in Denmark, 1977-2006", Obstet Gynecol, 122, pp.608~617 (2013)
- Cardonick E, "Pregnancy-associated breast cancer : optimal treatment options", Int J Womens Health, 6, pp.935~943 (2014)
- Lee HY, "Melanoma:differences between Asian and Caucasian patients", Ann Acad Med Singapore, 41, pp.17~20 (2012)
- Cancer prevalence by generation: 2012 web-based report, "National Cancer Information Center", National Cancer Information Center, ~ (2014)
- 정재훈, "Cost-of-Illness Trend of Thyroid Gland Disease in Korea", Endocrinology and Metabolism, 29(3), pp.248~250 (2014), 대한내분비학회
- Han MA, "Current status of thyroid cancer screening in Korea : results from a nationwide interview survey", Asian Pac J Cancer Prev, 12, pp.1657~1663 (2011)
- Lishner M, "Cancer in pregnancy", Ann Oncol, 14(Suppl 3), pp.iii31~iii36 (2003)
- 오상은, "A case of huge retroperitoneal liposarcoma in pregnancy", Obstetrics & Gynecology Science, 57(03), pp.236~239 (2014), 대한산부인과학회[DOI]
- Abramowicz JS, "Benefits and risks of ultrasound in pregnancy", Semin Perinatol, 37, pp.295~300 (2013)
- Bulas D, "Benefits and risks of MRI in pregnancy", Semin Perinatol, 37, pp.301~304 (2013)
- ACOG Committee on Obstetric Practice, "ACOG Committee Opinion. Number 299, September 2004 (replaces No. 158, September 1995). Guidelines for diagnostic imaging during pregnancy", Obstet Gynecol, 104, pp.647~651 (2004)
- Fenig E, "Pregnancy and radiation", Cancer Treat Rev, 27, pp.1~7 (2001)
- Brent RL, "The effect of embryonic and fetal exposure to Xray, microwaves, and ultrasound: counseling the pregnant and nonpregnant patient about these risks", Semin Oncol, 16, pp.347~368 (1989)
- Savas N, "Gastrointestinal endoscopy in pregnancy", World J Gastroenterol, 20, pp.15241~15252 (2014)
- Cappell MS, "The fetal safety and clinical efficacy of gastrointestinal endoscopy during pregnancy", Gastroenterol Clin North Am, 32, pp.123~179 (2003)
- Jaspers VK, "Gastric cancer in pregnancy: do pregnancy, age or female sex alter the prognosis? Case reports and review", Eur J Obstet Gynecol Reprod Biol, 87, pp.13~22 (1999)
- Pereg D, "Cancer in pregnancy: gaps, challenges and solutions", Cancer Treat Rev, 34, pp.302~312 (2008)
- Malangoni MA, "Gastrointestinal surgery and pregnancy", Gastroenterol Clin North Am, 32, pp.181~200 (2003)
- Amant F, "Management of cancer in pregnancy", Best Pract Res Clin Obstet Gynaecol, 29, pp.741~753 (2015)
- Aviles A, "Growth and development of children of mothers treated with chemotherapy during pregnancy : current status of 43 children", Am J Hematol, 36, pp.243~248 (1991)
- Lishner M, "Cancer chemotherapy during pregnancy : consortium of cancer in pregnancy evidence", Can Fam Physician, 47, pp.41~42 (2001)
- Amant F, "Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older : an observational study", Lancet Oncol, 13, pp.256~264 (2012)
- Cunningham FG, "Williams obstetrics" (2014), McGraw-Hill